|
Confirmed Invited Speakers  | Ann Albright, Division of Diabetes Translation, Centres for Disease Control and Prevention, United States Ann Albright is the director of the Division of Diabetes Translation at the Center for Disease Control (CDC) in Atlanta, Georgia (Jan 2007 – present), Division of Diabetes Translation www.cdc.gov/diabetes/about/ where the aim is to translate diabetes research into daily practice, define the diabetes burden, public health surveillance, conduct applied translational research and develop state based diabetes prevention and control programs. This also includes implementing the National Diabetes Education Program, coordinating media strategies and providing public information. Also Ann is the president American Diabetes Association Healthcare and Education Committee. Ann has received: American Dietetic Association Excellence in Practice Award 2004 and also the American Diabetes Association Outstanding Educator in Diabetes Award 2009 |  | Elizabeth Barrett-Connor, MD, Chief of the Division of Epidemiology, Distinguished Professor in the Departments of Family and Preventive Medicine and Medicine at the University of California, San Diego School of Medicine, La Jolla, United States Dr Barrett-Connor earned a medical degree from Cornell University Medical College, in New York, New York. She completed an internal medicine internship and a residency at the University of Texas Southwestern Medical School, in Dallas, followed by postgraduate training in infectious diseases at the University of Miami School of Medicine, in Florida. Her research concerns healthy aging with a particular focus on gender differences and women’s health. She is author of more than 800 publications. Dr Barrett-Connor is founder and director of the Rancho Bernardo Heart and Chronic Disease Study, begun in 1972, with continuous support from the NIH. She has served as principal investigator of several multicenter clinical trials, including the Postmenopausal Estrogen/Progestin Interventions trial, the Heart and Estrogen-Progestin Replacement Study, the Raloxifene Use in the Heart study, and the Diabetes Prevention Program. Dr Barrett-Connor is Past President of the Epidemiology Section of the American Public Health Association, the Epidemiology Council of the American Heart Association, the Society for Epidemiologic Research, and the American Epidemiological Society. She has been a member of the Armed Forces Epidemiology Board, the Advisory Council of the National Institute on Aging, the Board of the Menopause Society, and the Advisory Committee of the Millennium Cohort Study. She is a Master of the American College of Physicians of Medicine and a member of the Institute of Medicine. Her many honors include the National Osteoporosis Foundation (4/2009) Living Legacy Award, Distinguished Lecture for the American Heart Association (11/2009), and 4 NIH MERIT awards.
|  | Ralph DeFronzo, Deputy Director, Texas Diabetes Institute, University of Texas, San Antonio. Ralph DeFronzo is the Deputy Director, Texas Diabetes Institute, University of Texas, San Antonio. His major interests focus on the pathogenesis and treatment of type 2 diabetes mellitus, the central role of insulin resistance in the metabolic-cardiovascular cluster of disorders-known collectively as the Insulin Resistance Syndrome, and the etiology and treatment of diabetic nephropathy. Using the euglycemic insulin clamp technique in combination with radioisotope turnover methodology, limb catheterization, indirect calorimetry, and muscle biopsy, he has helped to define the biochemical and molecular disturbances responsible for insulin resistance in type 2 diabetes mellitus.
|  | Rayaz Malik, Professor of Medicine & Consultant Physician in the Division of Cardiovascular Medicine, Manchester Royal Infirmary & University of Manchester, Manchester. Rayaz Malik is a Professor of Medicine & Consultant Physician in the Division of Cardiovascular Medicine, Manchester Royal Infirmary & University of Manchester, Manchester. He obtained his BSc., MSc. and MB ChB from the University of Aberdeen and his PhD from the University of Manchester. His research focuses on diabetic neuropathy and cardiomyopathy in both animal models and at a translational level in patients. He is an expert in the pathogenesis, assessment and treatment of diabetic neuropathy and has published and presented extensively on this. His research is currently funded by the NIH, JDRF, MRC, DUK and BHF and he is currently supervising 6 PhD’s and 4 MD’s.He was appointed to the Executive committee of the Neurodiab (The neuropathy study group of the European association for the study of diabetes) in September 2007. He is the associate editor for Diabetic Medicine and Journal of Brachial Plexus and Peripheral Nerve Injury.
|  | Jerry L. Nadler, Professor and Chairman of Internal Medicine and the Harry S. Mansbach Endowed Chair in Internal Medicine and Director of the Strelitz Diabetes Center at Eastern Virginia Medical School. Jerry L. Nadler, M.D. is Professor and Chairman of Internal Medicine and the Harry S. Mansbach Endowed Chair in Internal Medicine and Director of the Strelitz Diabetes Center at Eastern Virginia Medical School. Dr. Nadler has been a member of a Special Advisory Committee on Type I Diabetes with the Director of the National Institutes of Health Diabetes Institute. Dr. Nadler was also the Associate Director of the NIH funded Diabetes Endocrinology Research Center at the University of Virginia. Dr. Nadler has research funding from the NIH, Juvenile Diabetes Foundation, The Ella Fitzgerald Charitable Foundation and the Iacocca Foundation. Dr. Nadler is a standing member of the ADA and NIH grant review committees. Dr. Nadler is the scientific founder of the DiaKine Therapeutics, Inc., a start-up biopharmaceutical company developing new, proprietary drugs for unmet medical needs in diabetes and complications related to diabetes. His primary interest is the role of lipid and immune inflammatory pathways leading to beta cell damage and the complications of Diabetes.
| | Claire Palermo, Department of Nutrition and Dietetics at Monash University Claire is a dietitian and currently working as a lecturer for the Department of Nutrition and Dietetics at Monash University. Her career has spanned community and public health nutrition in Victoria and the Northern Territory. Her research and practice interests include capacity building and food access. Her PhD was an evaluation of a mentoring circle intervention for post graduate professional development of dietitians. She is passionate about public health nutrition workforce development and preparing entry-level dietitians for a career in public health. | | | Bruce Verchere, Departments of Pathology & Laboratory Medicine and Surgery, University of British Columbia, Canada Bruce Verchere is a Professor in the Departments of Pathology & Laboratory Medicine and Surgery at the University of British Columbia (UBC) in Vancouver, head of the Diabetes Research Program at the Child & Family Research Institute at BC Children’s Hospital, and holds the Irving K Barber Chair in Diabetes Research. He received his PhD from the Department of Physiology at UBC in 1991, and then pursued postdoctoral fellowship training in diabetes research in Seattle and Geneva, before returning to Vancouver in 1997. His research aims to understand how pancreatic islet beta cells function and why they are killed or are dysfunctional in both type 1 and type 2 diabetes and in transplanted islets. In 2006, he became a Senior Scholar of the Michael Smith Foundation for Health Research and was awarded the Canadian Diabetes Association Young Scientist Award. He is currently chair of the National Research Council of the Canadian Diabetes Association, Co-Chair of the Juvenile Diabetes Research Foundation Group II Islet Biology and Transplantation Committee grant review committee, and Chair of the Diabetes, Obesity and Lipoproteins grant review panel of the Canadian Institutes of Health Research. He was co-chair of the Canadian Diabetes Association Clinical & Scientific Session National Conference in 2007 and 2008.
|
|